Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
株式のランク #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
株価
$3.83
時価総額
$464.45M
変化(1日)
-1.63%
変化(1年)
17.17%
TW
取引 Gongwin Biopharm Holdings Co., Ltd. (6617)

カテゴリー

Gongwin Biopharm Holdings Co., Ltd.(6617)の株価履歴
終値の最高値: $3.43 (2026-08-01)

終値の最安値: $2.71 (2017-02-01)
Gongwin Biopharm Holdings Co., Ltd. の株価履歴(2017 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU